Cargando…

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum

Detalles Bibliográficos
Autores principales:	Chen, Jiu, Wang, Siyu, Chen, Rong, Liu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914052/ https://www.ncbi.nlm.nih.gov/pubmed/35283754 http://dx.doi.org/10.3389/fnagi.2022.848719

Ejemplares similares

Editorial: Measurable brain and cognitive reserve: The implication of neuroimaging biomarkers in the normal aging process
por: Huang, Chu-Chung, et al.
Publicado: (2022)

Editorial: Biomarkers from multi-tracer and multi-modal neuroimaging in age-related neurodegenerative diseases
por: Nie, Binbin
Publicado: (2022)

X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study
por: Wang, Kai-Wen, et al.
Publicado: (2023)

Effects of preventive interventions on neuroimaging biomarkers in subjects at-risk to develop Alzheimer's disease: A systematic review
por: Perus, Lisa, et al.
Publicado: (2022)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer’s disease
por: Sheng, Can, et al.
Publicado: (2023)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

Early-stage differentiation between Alzheimer’s disease and frontotemporal lobe degeneration: Clinical, neuropsychology, and neuroimaging features
por: Li, Pan, et al.
Publicado: (2022)

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?
por: Mirkin, Sophia, et al.
Publicado: (2023)

Differential Patterns of Domain-Specific Cognitive Complaints and Awareness Across the Alzheimer’s Disease Spectrum
por: Cacciamani, Federica, et al.
Publicado: (2022)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Acupuncture on mild cognitive impairment: A systematic review of neuroimaging studies
por: Yin, Zihan, et al.
Publicado: (2023)

Neuropsychiatric Symptoms Mediated the Relationship Between Odor Identification and Cognition in Alzheimer's Disease Spectrum: A Structural Equation Model Analysis
por: Wang, Qiang, et al.
Publicado: (2022)

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias
por: Giménez-Llort, Lydia
Publicado: (2023)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Editorial: Improving memory deficits in Alzheimer's disease
por: Wang, Fushun, et al.
Publicado: (2022)

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer’s disease spectrum
por: Christopher-Hayes, Nicholas J., et al.
Publicado: (2023)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

Brain disorder prediction with dynamic multivariate spatio-temporal features: Application to Alzheimer’s disease and autism spectrum disorder
por: Qiao, Jianping, et al.
Publicado: (2022)

Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals
por: Lee, Dong Hyuk, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias
por: Ibáñez, Agustín, et al.
Publicado: (2022)

Editorial: New developments in understanding brain and cerebromicrovascular aging: Toward prevention of vascular cognitive impairment and Alzheimer's disease
por: Sanford, Madison, et al.
Publicado: (2022)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease
por: Li, Lixia, et al.
Publicado: (2022)

Abnormal regional homogeneity in right caudate as a potential neuroimaging biomarker for mild cognitive impairment: A resting-state fMRI study and support vector machine analysis
por: Gao, Yujun, et al.
Publicado: (2022)

Editorial: Methods and applications in Alzheimer's disease and related dementias
por: Yogi, Alvaro, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias: 2022
por: Ibáñez, Agustín, et al.
Publicado: (2023)

Multimodality neuroimaging in vascular mild cognitive impairment: A narrative review of current evidence
por: Liu, Qiuping, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
por: Chen, Chun-Yan, et al.
Publicado: (2023)

Diagnosis of Alzheimer’s disease via resting-state EEG: integration of spectrum, complexity, and synchronization signal features
por: Zheng, Xiaowei, et al.
Publicado: (2023)

Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2022)

Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
por: Ju, Ting, et al.
Publicado: (2022)

Different Profiles of Spatial Navigation Deficits In Alzheimer’s Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2022)

Differential Abnormality in Functional Connectivity Density in Preclinical and Early-Stage Alzheimer's Disease
por: Song, Yu, et al.
Publicado: (2022)

Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients
por: Chen, Xueping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o40qka4otmj85j09p928i0jhp7